Biofrontera Inc.
BFRI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $6,654 | $4,413 | $6,013 |
| - Cash | $3,417 | $7,239 | $1,785 | $5,905 |
| + Debt | $4,598 | $5,004 | $4,863 | $4,922 |
| Enterprise Value | – | $4,419 | $7,491 | $5,030 |
| Revenue | $6,988 | $9,030 | $8,588 | $12,559 |
| % Growth | -22.6% | 5.1% | -31.6% | – |
| Gross Profit | $5,066 | $6,650 | $5,513 | $7,287 |
| % Margin | 72.5% | 73.6% | 64.2% | 58% |
| EBITDA | -$6,333 | -$4,966 | -$3,865 | -$1,123 |
| % Margin | -90.6% | -55% | -45% | -8.9% |
| Net Income | -$6,649 | -$5,324 | -$4,203 | -$1,396 |
| % Margin | -95.1% | -59% | -48.9% | -11.1% |
| EPS Diluted | -0.62 | -0.57 | -0.76 | 2.97 |
| % Growth | -8.8% | 25% | -125.6% | – |
| Operating Cash Flow | -$3,823 | -$3,045 | -$4,117 | -$1,017 |
| Capital Expenditures | $1 | -$1 | -$3 | -$1 |
| Free Cash Flow | -$3,822 | -$3,046 | -$4,120 | -$1,018 |